A Landmark Trial Cracks a Four-Decade Default, The Drug That Outlived Its Evidence
A landmark NEJM trial just challenged four decades of post-heart-attack dogma When “keep taking it” stops being the right answer…
The FDA Just Lost Its Commissioner and Pharmacy Is Entering Its Most Uncertain Regulatory Era in Decades
On May 12, 2026, FDA Commissioner Dr. Marty Makary resigned. Within days, the acting heads of both the Center for Drug Evaluation and Research…
Beyond the Cysts: The Real Story of PMOS
The renaming of PCOS to PMOS is the most consequential disease-nomenclature overhaul in a generation For decades, clinicians and patients have…
U.S. Drug Spending Just Crossed $1 Trillion. Pharmacists Are at the Center of Every Dollar
ASHP released its annual drug expenditures report on April 30, 2026, and the headline number stopped the healthcare industry cold. For the…
Your Ozempic Patients Are Drinking Less, Here’s Why That’s Not a Coincidence
A landmark RCT is changing the conversation around alcohol use disorder The numbers that stopped addiction specialists mid-sentence The most…